These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3889965)

  • 41. Drug monitoring of clomipramine and desmethylclomipramine in depressed patients using a new liquid chromatographic assay.
    Diquet B; Thomaré P; Bocquentin M; Diviné C
    Biomed Chromatogr; 1993; 7(2):59-63. PubMed ID: 8485374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
    J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
    Noguera R; Altuna R; Alvarez E; Ayuso JL; Casais L; Udina C
    J Affect Disord; 1991 Jul; 22(3):119-24. PubMed ID: 1918655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum cortisol concentration in patients with major depression after treatment with clomipramine.
    Piwowarska J; Wrzosek M; Radziwoń-Zaleska M; Ryszewska-Pokraśniewicz B; Skalski M; Matsumoto H; Biernacka-Bazyluk A; Szelenberger W; Pachecka J
    Pharmacol Rep; 2009; 61(4):604-11. PubMed ID: 19815942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amineptine in the management of the depressive syndromes.
    Scarzella L; Scarzella R; Mailland F; Bergamasco B
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):429-39. PubMed ID: 4070645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement in depressive illness is not associated with altered release of neurophysins over a course of ECT.
    Scott AI; Shering PA; Legros JJ; Whalley LJ
    Psychiatry Res; 1991 Jan; 36(1):65-73. PubMed ID: 2017524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression.
    Scantamburlo G; Hansenne M; Fuchs S; Pitchot W; Pinto E; Reggers J; Ansseau M; Legros JJ
    Psychoneuroendocrinology; 2005 Oct; 30(9):839-45. PubMed ID: 15964147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma.
    De Zeeuw RA; Westenberg HG; Van Praag HM; De Cuyper H
    Postgrad Med J; 1980; 56 Suppl 1():120-6. PubMed ID: 7393821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine.
    Jones RB; Luscombe DK
    Postgrad Med J; 1977; 53 Suppl 4():63-76. PubMed ID: 758091
    [No Abstract]   [Full Text] [Related]  

  • 53. Opiate receptor sensitivity in depressed patients before and after clomipramine treatment.
    Naber D; Jungkunz G
    J Affect Disord; 1986; 11(1):59-62. PubMed ID: 3020108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response.
    Linnoila M; Seppala T; Mattila MJ; Vihko R; Pakarinen A; Skinner T
    Arch Gen Psychiatry; 1980 Nov; 37(11):1295-9. PubMed ID: 7436691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of antidepressant treatment with clomipramine on hormonal responses to thyrotropin-releasing hormone and insulin-induced hypoglycemia: implications for the "monoamine-hypothesis".
    Langer G; Karobath M; Sieghart W; Aschauer H; Placheta P; Spona J
    Pharmacopsychiatria; 1981 May; 14(3):100-6. PubMed ID: 6789342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum clomipramine and metabolite levels in four nursing mother-infant pairs.
    Wisner KL; Perel JM; Foglia JP
    J Clin Psychiatry; 1995 Jan; 56(1):17-20. PubMed ID: 7836334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.
    Balant-Gorgia AE; Balant LP; Garrone G
    Ther Drug Monit; 1989; 11(4):415-20. PubMed ID: 2741190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine.
    Møller SE; Reisby N; Ortmann J; Elley J; Krautwald O
    J Affect Disord; 1981 Sep; 3(3):231-44. PubMed ID: 6456290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.